ACC 2022 Conference Coverage
P

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendations for HFrEF and HFmrEF Treatment

By ACC 2022 Conference Coverage FEATURING Paul Heidenreich
By ACC 2022 Conference Coverage FEATURING Paul Heidenreich
22,662 views
April 21, 2022
Comments 8
Login to view comments. Click here to Login

Featured Video

02:02
Boehringer Ingelheim and Lilly Cardiology

Overcoming Barriers to HFrEF GDMT Use

Feat. N. Singh

Featured Video

03:26
Boehringer Ingelheim and Lilly Cardiology

Optimal Medical Therapy for Patients with HFrEF - Four Pharmacologic…

Feat. N. Singh, N. Lepor, K. Watson, M. Budoff, R. Chilton

Related Videos

64:45

Primer on Diabetes Management

Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

S. Inzucchi

44.7K views
11:25

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

21.4K views
27:14

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

MUSC Cardiology

R. Mentz

14.3K views
18:43

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

ASPC 2019 Congress on CVD Prevention

R. DeFronzo

12.3K views
11:49

Noninvasive Activation Patterns in Conduction System Pacing - Compar…

7th Annual Physiology of Pacing Symposium

Z. Whinnett

22 views
26:01

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Cardiology Fiesta 2017

R. DeFronzo

9.6K views
27:24

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

8.7K views
17:44

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

Rita Jermyn

8.6K views
37:00
CCM® Therapy

CCM® Therapy — Why Wait? (Case-Based Approach)

Feat. A. Panico, R. Doshi, J. Senfield
09:52

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

AHA 2022 Conference Coverage

R. Mentz

7.6K views
13:07

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

Michelle Kittleson

6.3K views
61:49

Management of Heart Failure

Obafemi Awolowo University

O. A. Akinyele

542 views
35:16

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Scripps Health

M. Kittleson

5.4K views
21:02

Cardiotoxicity: Anthracyclines

Scripps Health

M. Davis

37 views
18:00

ACC 2023: Catch Them Before They Fall - Syncope Guidelines in Action

ACC 2023 Conference Coverage

B. Olshansky

5.1K views
12:18
CCM® Therapy

HRS 2024: Cardiac Contractility Modulation - Don’t Wait!

Feat. R. Kahwash
17:29

Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics

UCLA Health

D. Vucicevic

241 views
12:08
CCM® Therapy

HRS 2024: Why Cardiac Contractility Modulation?

Feat. J. Singh
16:30

The Valve Trials Are Done: Interventional HFpEF Is the Next Big Thing

Northwestern Medicine Bluhm Cardiovascular Institute

S. Shah

41 views
12:03
Boston Scientific

Atrioventricular Optimization Improves Cardiac Resynchronization Res…

Feat. M. Gold
AUTOPLAY